Missing Data in Clinical Studies provides a comprehensive account of the problems arising when data from clinical and related studies are incomplete, and presents the reader with approaches to effectively address them. The text provides a critique of conventional and simple methods before moving on
Missing Data in Clinical Studies
β Scribed by Geert Molenberghs, Michael G. Kenward(auth.)
- Year
- 2007
- Tongue
- English
- Leaves
- 508
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Missing Data in Clinical Studies provides a comprehensive account of the problems arising when data from clinical and related studies are incomplete, and presents the reader with approaches to effectively address them. The text provides a critique of conventional and simple methods before moving on to discuss more advanced approaches. The authors focus on practical and modeling concepts, providing an extensive set of case studies to illustrate the problems described.
- Provides a practical guide to the analysis of clinical trials and related studies with missing data.
- Examines the problems caused by missing data, enabling a complete understanding of how to overcome them.
- Presents conventional, simple methods to tackle these problems, before addressing more advanced approaches, including sensitivity analysis, and the MAR missingness mechanism.
- Illustrated throughout with real-life case studies and worked examples from clinical trials.
- Details the use and implementation of the necessary statistical software, primarily SAS.
Missing Data in Clinical Studies has been developed through a series of courses and lectures. Its practical approach will appeal to applied statisticians and biomedical researchers, in particular those in the biopharmaceutical industry, medical and public health organisations. Graduate students of biostatistics will also find much of benefit.Content:
Chapter 1 Introduction (pages 1β10):
Chapter 2 Key Examples (pages 11β25):
Chapter 3 Terminology and Framework (pages 27β37):
Chapter 4 A Perspective on Simple Methods (pages 39β54):
Chapter 5 Analysis of the Orthodontic Growth Data (pages 55β66):
Chapter 6 Analysis of the Depression Trials (pages 67β74):
Chapter 7 The Direct Likelihood Method (pages 75β92):
Chapter 8 The ExpectationβMaximization Algorithm (pages 93β104):
Chapter 9 Multiple Imputation (pages 105β117):
Chapter 10 Weighted Estimating Equations (pages 119β134):
Chapter 11 Combining GEE and MI (pages 135β143):
Chapter 12 Likelihood?Based Frequentist Inference (pages 145β162):
Chapter 13 Analysis of the Age?Related Macular Degeneration (pages 163β170):
Chapter 14 Incomplete Data and SAS (pages 171β182):
Chapter 15 Selection Models (pages 183β213):
Chapter 16 Pattern?Mixture Models (pages 215β247):
Chapter 17 Shared?Parameter Models (pages 249β251):
Chapter 18 Protective Estimation (pages 253β282):
Chapter 19 MNAR, MAR, and the Nature of Sensitivity (pages 283β312):
Chapter 20 Sensitivity Happens (pages 313β328):
Chapter 21 Regions of Ignorance and Uncertainty (pages 329β352):
Chapter 22 Local and Global Influence Methods (pages 353β415):
Chapter 23 The Nature of Local Influence (pages 417β430):
Chapter 24 A Latent?Class Mixture Model for Incomplete Longitudinal Gaussian Data (pages 431β450):
Chapter 25 The Age?Related Macular Degeneration Trial (pages 451β460):
Chapter 26 The Vorozole Study (pages 461β481):
π SIMILAR VOLUMES
<p><p>All anesthesiologists eventually face the fear of a βnear miss,β when a patientβs life has been put at risk. Learning from the experience is crucial to professionalism and the ongoing development of expertise. Drawing on forty-plus years of practice in major metropolitan hospitals in the Unite
<p><p>All anesthesiologists eventually face the fear of a βnear miss,β when a patientβs life has been put at risk. Learning from the experience is crucial to professionalism and the ongoing development of expertise. Drawing on forty-plus years of practice in major metropolitan hospitals in the Unite
Randomized clinical trials are the primary tool for evaluating new medical interventions. Randomization provides for a fair comparison between treatment and control groups, balancing out, on average, distributions of known and unknown factors among the participants. Unfortunately, these studies ofte